Welcome to our Evotec Blog.
Hope you will find our articles and resources relevant for your projects and interests.
Our experts are available for any additional information and to assist with your project challenges!
Just contact us.
Evotec and Immuneering to collaborate on Artificial Intelligence (“AI”) driven ligand identification for rare hereditary metabolic diseases
Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidates
Yumanity Therapeutics announces first clinical candidate for the potential treatment of Parkinson’s disease
Evotec and CENTOGENE sign global strategic partnership on drug discovery projects in rare genetic diseases
Evotec receives milestone payment for start of Phase II trial in its multi-target alliance with Bayer
Evotec confirm closing of transaction with Sanofi to accelerate infectious disease research and development
Evotec forms academic BRIDGE 'LAB591’ with Arix Bioscience and Fred Hutchinson Cancer Research Center
Evotec launches INDiGO®, a unique integrated drug development solution for accelerating early drug candidates into the clinic
Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal Diseases
Evotec joins forces with Academic Leaders to accelerate Drug Discovery in kidney diseases and build “Neplex”
Aptuit Announces Alignment of Organizational Structure to Integrated Solution Delivery: Henning Steinhagen Appointed as President, Research and Development Operations
Aptuit Selected as a Winner of Life Science Leader Global Award for Contract Drug Manufacturer in Multiple Categories
Bioversys AG and Aptuit Announce Collaboration to Identify Novel Approaches to Treat Serious Infections from Gram-negative Pathogens
Dementia Discovery Fund Acquires Small Molecule Library and Enters Strategic Partnership with Aptuit to Kickstart Dementia Drug Discovery Programmes
Aptuit announces drug discovery collaboration with Massachusetts General Hospital (MGH) to identify novel treatments for Gram-negative infections
Aptuit and Chiesi Initiate Integrated Discovery Project to Identify Novel Compounds for the Treatment of Idiopathic Pulmonary Fibrosis
Aptuit LLC and Dimension Therapeutics enter strategic partnership to advance select Dimension programs toward IND filing
Henning Steinhagen appointed as Executive Vice President Drug Discovery and Development and Site-Head Verona